Shockwave ®S4 Catheter IVL to Treat Infrapopliteal Calcified Stenoses and/or Occlusions in CLTI Patients (LEGACY)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-14

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will evaluate the safety and efficacy of Peripheral Intravascular Lithotripsy system with Shockwave S4 catheter® for the treatment of de novo, re-stenosis or re-occlusive,calcified chronic total occlusion (CTOs) lesions in patients with Critical Limb Threatening Ischemia (CLTI).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Shockwave IVL + DES

NCT05291247

Peripheral Arterial Disease Superficial Femoral Artery Stenosis Calcifications Vascular

UNKNOWN

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

NCT06713850

Peripheral Artery Disease (PAD) Chronic Limb Threatening Ischemia

RECRUITING

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

NCT05058456

Peripheral Arterial Disease

COMPLETED NA

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

NCT06112171

Peripheral Arterial Disease

RECRUITING NA

Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis

NCT02911623

Peripheral Arterial Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present study is designed as a multicentre, prospective, single-arm, observational study.

All eligible subjects for undergoing intervention with Shockwave S4 catheter® Peripheral Intravascular Lithotripsy (IVL) at sites participating in the study will be considered for enrolment and will be asked to give consent prior to participating.

Subjects will be considered enrolled in the study at the time written informed consent is given to the use of their personal data. Once patients are enrolled, their demographics, medical history, disease-relevant conditions, treatment details and outcomes will be collected for up to 12 months from the procedure.

The study will collect information about the medical care patients receive during their planned procedure. No additional testing or procedures will be done.

The procedure with Shockwave S4 catheter® Peripheral Intravascular Lithotripsy (IVL) will be performed as per the current instructions for use.

After discharge all patients will attend clinic visits at 30 days (±14 days), 6 months (±30 days),12 months (±30 days).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Disease Critical Limb-Threatening Ischaemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Patient has signed an approved informed consent form
* Patient with Critical Limb Ischaemia, Rutherford category 4 (ischaemic rest pain), 5(minor tissue loss) or 6 (major tissue loss)
* Patient with Stenotic (\>50% luminal loss) or occluded infrapopliteal artery, including the tibiofibular trunk, the anterior tibial artery, the posterior tibial artery and the peroneal artery
* The vascular lesion length will be no longer than 150 mm.
* Patient with no significant disease at the inflow: common iliac, external iliac, superficial femoral and popliteal artery on the ipsilateral side prior to enrollment, and patient with no significant disease at the outflow - runoff to ankle level: plantar for posterior tibial, pedal for anterior tibial, anterior and posterior perforant branches for peroneal vessels or previous successful revascularization of the disease segments (inflow-outflow)
* Live expectancy \> 1 year.
* Presence at least ≥1 filling pedal vessel on the target limb.

Exclusion Criteria

* Subject pregnant or planning to become pregnant during the study
* Subject no able to perform the follow up or other factors making clinical follow-up difficult
* Acute or Subacute limb ischaemia which requires thrombolysis as first treatment modality or previous thrombolytic therapy in the last 48-72 hours.
* Known allergy to concomitant medication, antiplatelet anti-coagulant or thrombolytic medication
* Poor inflow due to ipsilateral stenoses or occlusions of the iliac or femoropopliteal arteries
* Significant stenoses (\> 50%) distal to the target lesion that might require revascularization or impede run-off
* Desert foot condition. No Patent foot main arteries
* Subject enrolled in another investigational study that has not reached its primary endpoint

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No